G&J Assistive Health Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 0.42%
(FY 2022)
- Profit -1.38%
(FY 2022)
- Ebitda 18.84%
(FY 2022)
- Net Worth 80.49%
(FY 2022)
- Total Assets 32.80%
(FY 2022)
About G&J Assistive Health Products
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jigisha Chaudhary, Aniruddh Patel, and Sarita Patel serve as directors at the Company.
- CIN/LLPIN
U74999GJ2020PTC113266
- Company No.
113266
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at G&J Assistive Health Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarita Patel  | Director | 19-Mar-2020 | Current |
Jigisha Chaudhary  | Director | 19-Mar-2020 | Current |
| Aniruddh Patel | Director | 19-Mar-2020 | Current |
Financial Performance of G&J Assistive Health Products.
G&J Assistive Health Products Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.42% increase. The company also saw a slight decrease in profitability, with a 1.38% decrease in profit. The company's net worth Soared by an impressive increase of 80.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G&J Assistive Health Products?
Unlock access to G&J Assistive Health Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at G&J Assistive Health Products?
G&J Assistive Health Products has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G&J Assistive Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G&J Assistive Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
